Detalles de la búsqueda
1.
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma.
Am J Respir Crit Care Med
; 209(3): 262-272, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38016003
2.
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry.
Ann Allergy Asthma Immunol
; 132(1): 42-53, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37640263
3.
Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.
ERJ Open Res
; 9(2)2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37020841
4.
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry.
J Allergy Clin Immunol Pract
; 11(9): 2732-2747, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37301430
5.
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy.
J Asthma Allergy
; 15: 1491-1510, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36303891
6.
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry".
J Allergy Clin Immunol Pract
; 12(2): 536-539, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38336403
Resultados
1 -
6
de 6
1
Próxima >
>>